Gelesis Holdings Inc.
Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Furt… Read more
Gelesis Holdings Inc. (GLSHQ) - Total Assets
Latest total assets as of June 2023: $95.88 Million USD
Based on the latest financial reports, Gelesis Holdings Inc. (GLSHQ) holds total assets worth $95.88 Million USD as of June 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Gelesis Holdings Inc. - Total Assets Trend (2020–2022)
This chart illustrates how Gelesis Holdings Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Gelesis Holdings Inc. - Asset Composition Analysis
Current Asset Composition (December 2022)
Gelesis Holdings Inc.'s total assets of $95.88 Million consist of 22.7% current assets and 77.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.2% |
| Accounts Receivable | $8.45 Million | 8.2% |
| Inventory | $6.87 Million | 6.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $13.41 Million | 13.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2022)
This chart illustrates how Gelesis Holdings Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Gelesis Holdings Inc.'s current assets represent 22.7% of total assets in 2022, an increase from 0.2% in 2020.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2022, up from 0.2% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 13.0% of total assets.
Gelesis Holdings Inc. Competitors by Total Assets
Key competitors of Gelesis Holdings Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Gelesis Holdings Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Gelesis Holdings Inc. generates 0.25x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Gelesis Holdings Inc. is currently not profitable relative to its asset base.
Gelesis Holdings Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.32 | 1.68 | 0.34 |
| Quick Ratio | 0.25 | 1.17 | 0.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-51.86 Million | $ 24.94 Million | $ -1.07 Million |
Gelesis Holdings Inc. - Advanced Valuation Insights
This section examines the relationship between Gelesis Holdings Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -29.4% |
| Total Assets | $103.32 Million |
| Market Capitalization | $5.66K USD |
Valuation Analysis
Below Book Valuation: The market values Gelesis Holdings Inc.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Gelesis Holdings Inc.'s assets decreased by 29.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Gelesis Holdings Inc. (2020–2022)
The table below shows the annual total assets of Gelesis Holdings Inc. from 2020 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $103.32 Million | -29.38% |
| 2021-12-31 | $146.30 Million | -47.14% |
| 2020-12-31 | $276.77 Million | -- |